Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Allergy and Asthma Reports
Erschienen in: Current Allergy and Asthma Reports 7/2016

01.07.2016 | Allergic Skin Diseases (L Fonacier, Section Editor)

Natural (Mineral, Vegetable, Coconut, Essential) Oils and Contact Dermatitis

verfasst von: Vermén M. Verallo-Rowell, Stephanie S. Katalbas, Julia P. Pangasinan

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Natural oils include mineral oil with emollient, occlusive, and humectant properties and the plant-derived essential, coconut, and other vegetable oils, composed of triglycerides that microbiota lipases hydrolyze into glycerin, a potent humectant, and fatty acids (FAs) with varying physico-chemical properties. Unsaturated FAs have high linoleic acid used for synthesis of ceramide-I linoleate, a barrier lipid, but more pro-inflammatory omega-6:-3 ratios above 10:1, and their double bonds form less occlusive palisades. VCO FAs have a low linoleic acid content but shorter and saturated FAs that form a more compact palisade, more anti-inflammatory omega-6:-3 ratio of 2:1, close to 7:1 of olive oil, which disrupts the skin barrier, otherwise useful as a penetration enhancer. Updates on the stratum corneum illustrate how this review on the contrasting actions of NOs provide information on which to avoid and which to select for barrier repair and to lower inflammation in contact dermatitis genesis.
Literatur
1.
Draelos ZD. Cosmetics and skin care products. A historical perspective. Dermatol Clin. 2000;18(4):557–9.CrossRefPubMed
2.
DeNavarre MG. Oils and fats, the historical cosmetics. J Oil Chem Soc. 1978;55:435–7.CrossRef
3.
4.
Rawlings AV, Lombard KJ. A review on the extensive skin benefits of mineral oil. Int J Cosmet Sci. 2012;34-511.
5.
Stamatas GN. Mineral oil in skin care: safety profile. In: Pappas A, editor. Lipids and skin health. New York: Springer Science + Business Media; 2015. p. 291–9.
6.
7.
Oils (Argan, Borage seed, Jojoba, Olive, Safflower, Tamanu). In Baumann L, editor, Cosmeceuticals and Cosmetic Ingredients. McGraw-Hill Education: 2015. 23-47.
8.
9.
Kumar PKP, Krishna AGG. Physicochemical characteristics of commercial coconut oils produced in India. Grass Y Aceites. 2015;66(1):e062ISSN-L:0017-3495.
10.
Nguyen SA, More DR, Whisman BA, Hagan LL. Cross-reactivity between coconut and hazelnut proteins in a patient with coconut anaphylaxis. Ann Allergy Asthma Immunol. 2004;92(2):281–4.CrossRefPubMed
11.
Fowler JF, Fowler LM, Hunter JE. Allergy to cocamidopropyl betaine may be due to amidoamine: a patch test and product use test study. Contact Dermatitis. 1997;37(6):276–81.CrossRefPubMed
12.
Knopp E, Watsky K. Eyelid dermatitis: contact allergy to 3-(dimethylamino)propylamine. Dermatitis. 2008;19(6):328–33.PubMedPubMedCentral
13.••
Ali B, Al-Wabel NA, Shams S, Ahamad A, Khan AS, Anwar F. Review article essential oils used in aromatherapy: a systemic review. Asian Packag J Trop Biomed. 2015;5(8):601–11. This review enumerates the various oils used by people who do aromatherapy.
14.
15.
Lawless J. The encyclopedia of essential oils. 2nd ed. London: Harper Thorsons; 2014.
16.•
Uter W, Schmidt E, Geier J, Lessmann H, Schnuch A, Frosch P. Contact allergy to essential oils: current patch test results (2000–2008) from the Information Network of Departments of Dermatology (IVDK). Contact Dermatitis. 2010;63(5):277–83. A European study focusing on the contact dermatitis produced by this group of oils.
17.
Kejlova K, Jirova D, Bendova H, Gajdos P, Kolarova H. Phototoxicity of essential oils intended for cosmetic use. Toxicol in Vitro. 2010;24(8):2084–9.CrossRefPubMed
18.••
de Groot AC, Schmidt E. Review essential oils, part I: introduction. Dermatitis. 2016;27(2):39–42. Another important contribution towards understanding contact dermatitis by essential oils.CrossRefPubMed
19.••
Cheng J, Zug KA. Review: fragrance allergic contact dermatitis. Dermatitis. 2014;25(5):232–45. An update on fragrance contact dermatitis.CrossRefPubMed
20.
DeGroot AC, Frosch PJ. Adverse reactions to fragrances. A clinical review. Contact Dermatitis. 1997;36(2):57Y86.
21.•
Storrs FJ. Allergen of the year: fragrance. Dermatitis. 2007;18(1):3–7. A discussion on why fragrance became the allergen of the year in 2007.CrossRefPubMed
22.
Warshaw EM, Maibach HI, Taylor JS, Sasseville D, DeKoven JG, Zirwas MJ. North American Contact Dermatitis Group patch test results: 2011–2012. Dermatitis. 2015;26(1):49–59.CrossRefPubMed
23.
EU Directive 2003/15/EC, Official Journal of the European Union, 6 66.26, 11.3.2003
24.
Martin SF. Contact dermatitis: from pathomechanisms to immunotoxicology. Exp Dermatol. 2012;21:382–9.CrossRefPubMed
25.
Ale SI, Maibach HI. Irritant contact dermatitis vs allergic contact dermatitis. In: Chew AL, Maibach HI, editors. Irritant dermatitis. Berlin: Springer; 2005. p. 11–8.
26.
Proksch E, Brasch J. Abnormal epidermal barrier in the pathogenesis of contact dermatitis. Clin Dermatol. 2012;30:335–44.CrossRefPubMed
27.
Feingold KR, Schmuth M, Elias PM. The regulation of permeability barrier homeostasis. J Investig Dermatol. 2007;127(7):1574–6.CrossRefPubMed
28.
Spiekstra SW, Toebak MJ, Sampat-Sardjoepersad S, et al. Induction of cytokine (interleukin-1α and tumor necrosis factor-α) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure. Exp Dermatol. 2005;14(2):109–16.CrossRefPubMed
29.
Tang H, Schlapbach C, Hassan AS, Simon D, Yawalkar N. Characterization of dendritic cells and macrophages in irritant contact dermatitis. J Dermatol Sci. 2010;57(3):216–8.CrossRefPubMed
30.
He D, Wu L, Kim HK, Li H, Elmets CA, Xu H. IL-17 and IFN-γ mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses. J Immunol. 2009;183(2):1463–70.CrossRefPubMedPubMedCentral
31.
Meller S, Lauerma AI, Kopp FM, et al. Chemokine responses distinguish chemical-induced allergic from irritant skin inflammation: memory T cells make the difference. J Allergy Clin Immunol. 2007;119(6):1470–80.CrossRefPubMed
32.
Elias PM. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol. 1983;80 (Suppl):44s-49s.
33.••
Wooi NK, Lau WM. Skin deep: the basics of human skin structure and drug penetration. In: Dragicevie N, Maibach HI, editors. Percutaneous penetration enhancers chemical methods in penetration enhancement: drug manipulation strategies and vehicle effects. Berlin: Springer; 2015. p. 3–11. An excellent basis for understanding natural oils and their effects on the skin.
34.
Wertz P, Norlén L. “Confidence intervals” for the “true” lipid compositions of the human skin barrier? In: Forslind B, Linberg M (eds) Skin, hair, and nails structure and function, CRC Press 2003: 75-96.
35.
Norlen L. Skin barrier structure and function: the single gel phase model. J Investig Dermatol. 2001;117(4):830–6.CrossRefPubMed
36.
Iwai I, Han H, den Hollander L, Svensson S, Ofverstedt L-G, Anwar J, et al. The human skin barrier is organized as stacked bilayers of fully extended ceramics with cholesterol molecules associated with the creamed sphenoid moiety. J Investig Dermal. 2012;132:2215–25.CrossRef
37.••
Norlén L. Molecular structure and function of the skin barrier. In: Dragicevic N, Maibach HI, editors. Percutaneous penetration enhancers chemical methods in penetration enhancement: drug manipulation strategies and vehicle effects. Berlin: Springer; 2015. p. 39–42. This continues with more basic knowledge about the barrier layer of the skin as background to understanding natural oils and their effects on the barrier.
38.••
Elias PM. Physiologic lipids for barrier repair in Ch 7: 49–54 in Cosmeceuticals 3rd Ed. Draelos ZD, Dover JS, Alam M. editors. Elsevier 2016. This focuses on the lipids of the barrier and makes us understand how natural oils may be incorporated in it.
39.
Baumann L. Moisturizing agents in Leslie Baumann cosmeceutical and cosmetic ingredients 1st ed. McGraw Hill Education; 2015 :20-24.
40.••
Stamatas GN. Mineral oil in skin care: safety profile; Ch 19: 291-299. In: Pappas A, editor. Lipids and skin health. NY: Springer Science + Business Media; 2015. A basic understanding for why mineral oil has been preferred by dermatologists for many years.
41.
42.
Bruggermann H, Henne A, Hoster F, Liesegang H, Wiezer A, Strittmatter A, et al. The complete genome sequence of propionibacterium acnes, a commensal of human skin. Science. 2004;305:671–3.CrossRef
43.
Lee YW, Lee SY, Lee Y, Jung WH. Evaluation of expression of lipase and phospholipase of Malassezia restricts in patients with seborrheic dermatitis. Ann Dermatol. 2013;25(3):310–4.CrossRefPubMedPubMedCentral
44.••
Enig MG. Knowing the basic facts about fats and oils, Chapter 1: 9–50 In Enig MG Know your fats: the complete primer for understanding the nutrition of fats, oils, and cholesterol, Bethesda Press 2002. Great for knowing nomenclature of fats.
45.•
Agero LA, Verallo-Rowell VM. A randomized double-blind controlled trial comparing extra virgin coconut oil with mineral oil as a moisturizer for mild to moderate xerosis. Dermatitis. 2004;15(3):109–16. The first study on coconut oil as a moisturizer.
46.
Escuadro MO, Maano MMC, Dofitas BL. A randomized assessor-blinded controlled trial on the efficacy and safety of virgin coconut oil versus mineral oil as a therapeutic moisturizer for senile xerosis. Poster Presentation/ Published in Abstracts American Contact Dermatitis Society Annual Meeting 2013.
47.
Berg JM, Tymoczko JL, Stryer L. Lipids and cell membranes. In: Biochemistry. 5th ed. New York: WH Freeman; 2002:321.
48.
Menon GK. Skin basics structure and function, Ch 1 in Lipids and Skin Health. Pappas A editor. Springer 2015.
49.
Zettersten EM, Ghadially R, Feingold KR, et al. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J Am Acad Dermatol. 1997;37(3):403.CrossRefPubMed
50.
Appa Y, Ordh D. Glycerin: a natural ingredient for moisturizing skin, dry skin and moisturizers: chemistry and function. Boca Raton: CRC Press; 1999.
51.
Fluhr JW, Darlensi R, Surber C. Glycerol and the skin holistic approach to its origin and functions. Br J Dermatol. 2008;159(1):23–4.CrossRefPubMed
52.•
Mack Correa CM, Mao G, Saad P, Flach CR, Mendelsohn R, Walters RM. Molecular interactions of plant oil components with stratum corneum lipids correlate with clinical measures of skin barrier function. Exp Dermatol. 2014;23:39–4. A study on how natural oils become incorporated into the epidermal cells.
53.
Baumann L. Olive oil Ch 14: 37–40 in Baumann L ed Cosmeceuticals and cosmetic ingredients 1st ed. McGraw-Hill 2015.
54.
Man MQM, Feingold KR, Thornfeldt CR, et al. Optimization of physiological lipid mixtures for barrier repair. J Investig Dermatol. 1996;106:1096.CrossRef
55.
Roussel L, Abdayem R, Gilbert E, Pirot F, Haftek M. Influence of excipients on two elements of the stratum corner barrier: intercellular lipids and epidermal tight junctions. in Percutaneous penetration enhancers chemical methods in penetraten enhancement. Dragicevic N and Maibach HI editors. Springer 2015.
56.
Mao-Qiang M, Brown BE, Wu-Pong S, et al. Exogenous non-physiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol. 1995;131:809.CrossRefPubMed
57.
Madison KC, Howard EJ. Ceramides are transported through the Golgi apparatus in human keratinocytes in vitro. J investig Dermatol. 1996;106:1030.CrossRefPubMed
58.
Petrauskaite V, De Greyt WF, Kellens MJ. Physical refining of coconut oil: effect of crude oil quality and deodorization conditions on neutral oil loss. AOCS. 2000;77:581–6.
59.
Anastopoulous G, Zannikou Y, Stournas S, Kalligeros S. Transesterification of Vegetable Oils with Ethanol and Characterization of the Key Fuel Properties of Ethyl Esters. Energies. 2009;2:362–76.CrossRef
60.
Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetrate of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165–9.CrossRefPubMed
61.••
62.
Verallo-Rowell VM. Rx: coconuts! (The perfect health nut). Xlibris Philadelphia 2005:25-90.
63.
Naldi et al. Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol. 2014;170:634–64.CrossRefPubMed
64.••
Nicolaou A. Eicosanoids in skin inflammation. Prostaglandins Leukot Essent Fatty Acids. 2013;88:1131–8. This explains the inflammatory cascade affected by fatty acids from natural oils.
65.
Mc Cusker MM, Grant-Kels JM. Healing fats of the skin: the structural and immunologic role of the W-6 and W-3 fatty acids. Clin Dermatol. 2010;28:440–51.CrossRef
66.
Calder PC. Review of fatty acids and inflammatory processes. Nutrients 2010:355-374
67.
Eaton SB, Eaton 3rd SB, Konner MJ, Shostak M. An evolutionary perspective enhances understanding of human nutritional requirements. J Nutr. 1996;126(6):1732–40.PubMed
68.
Simopoulos AP. Evolutionary aspects of diet: fatty acids, insulin resistance and obesity. In: Van Itallie TB, Simopoulos AP, editors. Obesity: new directions in assessment and management. Philadelphia: Charles Press; 1995. p. 241–61.
69.••
Calder PC. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms, and clinical relevance. Biochem Biophys Acta. 2014. This continues the understanding of pro- and anti-inflammatory effects of fatty acids derived from natural oils.
70.
Kang JX. Balance of omega-6/omega-3 essential fatty acids is important for health. The evidence from gene transfer studies. World Rev Nutr Diet. 2005;95:93–102.CrossRefPubMed
71.
Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol. 2009;77(6):937–46.CrossRefPubMed
72.
Simoupoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Bull Med (Maywood). 2008;233(6):674–88.CrossRef
73.
Granados S, Quiles JL, Gil A, Ramírez-Tortosa MC. Lípidos de la dieta y cáncer. Nutr Hosp. 2006;21:44–54.
74.
Gomez C, Candela LM, Lopez B, Kohen VL. Importance of a balanced omega6/omega3 ratio for the maintenance of health. Nutritional recommendations. Nutr Hosp. 2011;26(2):323–9.
75.
76.••
Souza RJ, Mente A, Maroleanu A, Cozma A, Ha V, Kishibe T, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ. 2015;351:h3978. This explains why processing of natural oils produces trans fatty acids that have pro-inflammatory effects.
77.
Carocho M. Ferreira ICFR A review on antioxidants, prooxidants, and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem Toxicol. 2013;51:15–25.CrossRefPubMed
78.
Librado AS, Von Luigi MV. Phenolic-dependent anti-lipid perioxidative, antimodulatory and antioxidant activity of VCO in vitro. Int Food Res J 2013 (20) Bawa AS, Anilakumar KR Genetically modified foods: safety, risks and public concerns—a review. J Food Sci Technol. 2013;50(6):1035–46.CrossRef
79.
Bawa AS, Anilakuma KR. Genetically modified foods: safety, risks and public concerns—a review. J Food Sci Technol. 2013;50(6):1035–46.CrossRefPubMed
80.
Delaney B. Safety assessment of foods from genetically modified crops in countries with developing economies. Food Chem Toxicol. 2015;86:132–43.CrossRefPubMed
81.•
Dillague K, Syah-Tjundawan BS, Verallo-Rowell VM. The comparative antibacterial effects of virgin coconut oil versus virgin olive oil in atopic dermatitis: a double-blind randomized controlled trial. Dermatitis, 2008:308–314. Coconut oil was shown to have greater anti- Staph. aureus activity than olive oil, another type of natural oil.
82.••
Thormar H, Hilmarsson H, Bergsson G. Antimicrobial lipids: Role in innate immunity and potential use in prevention and treatment of infections. In: Méndez-Vilas A, editor. Microbial pathogens and strategies for combating them: science, technology and education, vol. 3. Formatex Research Center, Badajoz, Spain; 2013. pp. 1474–88. This is an important information source on the antimicrobial effects of natural oils.
83.
Evangelista MTP, Casintahan MFS, Villafuerte LL. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized double-blind clinical trial. Int J Dermatol. 2014;53(1):100–8.
84.
Fluhr JW, Darlenski R, Angelova-Fischer I, et al. Skin irritation and sensitization: mechanisms and new approaches for risk assessment. 1. Skin irritation. Skin Pharmacol Physiol. 2008;21:24–35.
85.
Cohen DE, Rao S, Brancaccio RR. Use of the North American Contact Dermatitis Group Standard 65-allergen series alone in the evaluation of allergic contact dermatitis: a series of 794 patients. Dermatitis. 2008;19(3):137–41.
86.
Uter W, Balzer C, Geier J, et al. Patch testing with patients’ own cosmetics and toiletries—results of the IVDK*, 1998–2002. Contact Dermatitis. 2005;53(4):226–33.
Metadaten
Titel
Natural (Mineral, Vegetable, Coconut, Essential) Oils and Contact Dermatitis
verfasst von
Vermén M. Verallo-Rowell
Stephanie S. Katalbas
Julia P. Pangasinan
Publikationsdatum
01.07.2016
Verlag
Springer US
Erschienen in
Current Allergy and Asthma Reports / Ausgabe 7/2016
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-016-0630-9

Weitere Artikel der Ausgabe 7/2016

Current Allergy and Asthma Reports 7/2016 Zur Ausgabe

Pediatric Allergy and Immunology (WK Dolen, Section Editor)

The Perception of Asthma Severity in Children

Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)

Immediate Drug Hypersensitivity

Food Allergy (T Green, Section Editor)

The Prevalence and Natural History of Food Allergy

Basic and Applied Science (I Lewkowich, Section Editor)

Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

HNO-Op. auch mit über 90?

16.04.2024 | Tonsillektomie | Nachrichten

Intrakapsuläre Tonsillektomie gewinnt an Boden

15.04.2024 | Hörsturz | Nachrichten

Bilateraler Hörsturz hat eine schlechte Prognose

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“
weitere anzeigen

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen